The FINANCIAL — The outcome of vaccine trials is being closely watched around the world. Pharmaceutical company AstaZeneca said Tuesday that it had paused global trials of its coronavirus vaccine in America as it is investigating one of the volunteers in United Kingdom who had a serious side effect – unexplained illness. It’s a standard precaution in vaccine trials that is meant to ensure experimental vaccines don’t cause serious reactions among participants. AstraZeneca described it as a routine pause in the case of an unexplained illness. The AstraZeneca vaccine, known as AZD1222, was invented by the University of Oxford and an associated…
Read More »
